MedPath

Development of new diagnostic methods using 5-ALA for tissue stump and lymph node metastasis of gastric cancer

Phase 2
Conditions
gastric cancer
Registration Number
JPRN-UMIN000018504
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Porphyria Patients with a history of hypersensitivity of 5-ALA or porphyrins Patients taking drugs that may cause photosensitivity (tetracycline antibiotics, sulfonamide-based formulation, new quinolone antibiotics, hypericin, St. John's wort-containing foods, etc) Patients who is or might be pregnant Patients who is determined inappropriate to participate in the study by the attending physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath